Floatz logo

Osilodrostat

Autonomous Cortisol Secretion (ACS)

Johns Hopkins UniversitySmall moleculePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Autonomous Cortisol Secretion (ACS) cohort.

Asset / SponsorPhaseRating
Semaglutide
University of Texas Southwestern Medical Center
N/AD

Same molecule, other indications

Osilodrostat is also rated in:

adrenal gland hyperfunctionDormant
BBB
Indicative ·
72 / 100
View asset →
Cushing disease due to pituitary adenomaDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →